학술논문
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML
Document Type
Article
Author
Cai, S.F.; Dunbar, A.J.; Chervin, J.; Heerema, N.A.; Levine, R.L.; Stein, E.M.; Huang, Y.; Lance, J.R.; Mao, H.C.; Shoben, A.; Chen, T.L.; Druggan, F.; Stefanos, M.; Mims, A.S.; Borate, U.; McNulty, S.N.; Druley, T.; Li, Y.; Baer, M.R.; Stock, W.; Kovacsovics, T.; Blum, W.G.; Schiller, G.J.; Olin, R.L.; Foran, J.M.; Litzow, M.; Lin, T.; Patel, P.; Collins, R.H.; Foster, M.C.; Boyiadzis, M.; Vergilio, J.-A.; Rosenberg, L.; Yocum, A.O.; Marcus, S.; Burd, A.; Druker, B.J.; Byrd, J.C.
Source
In: Blood Advances . (Blood Advances, 23 January 2024, 8(2):429-440)
Subject
Language
English
ISSN
24739537
24739529
24739529